Alibaba Health Information Technology Ltd. has announced its audited annual results for the fiscal year ended March 31, 2025. The company's total revenue reached RMB30,598.3 million, marking a 13.2% increase year-on-year. Net profit for the period rose significantly by 62.2% to RMB1,432.0 million. The adjusted net profit totaled RMB1,949.7 million, reflecting a 35.6% increase year-on-year, and the adjusted net profit margin improved from 5.3% to 6.4%. During the reporting period, Alibaba Health continued to see steady growth in its business operations, driven by advancements in the "Internet + Healthcare" industry. The company actively engaged in various sectors, including medical services management, primary health services, and health industry development, laying the groundwork for exploration in medical AI. The Tmall Healthcare Platform also contributed to the company's stable growth trajectory.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。